The Latest Breaking News from CVS Health

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.69% on an annualized basis producing an average annual return of 9.39%. Currently, CVS Health has a market capitalization of $126.32 billion.

A Relative Strength Rating upgrade for CVS Health shows improving technical performance.

According to Benzinga Pro, during Q1, CVS Health (NYSE:CVS) earned $2.31 billion, a 78.47% increase from the preceding quarter. CVS Health also posted a total of $76.83 billion in sales, a 0.29% increase since Q4.

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

CVS Health Corp (NYSE: CVS) shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guidance.

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

CVS Health Corp's (NYSE:CVS) Q1 sales increased 11.2% Y/Y to $76.83 billion, beating the consensus of $75.39 billion. Adjusted operating income increased 6.6% to $4.48 billion primarily due to increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of COVID-19 vaccinations in the Retail/LTC…

  CVS Health (NYSE:CVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.